FREZENT Biological Solutions Revenue

Biotechnology Research • Manhattan, New York, United States • 1-10 Employees

FREZENT Biological Solutions revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contact at FREZENT Biological Solutions

Natasha Shtraizent

Founder, Chief Executive Officer

Company overview

Headquarters	7 Pennsylvania Plaza, New York, NY 10001, US
Website	frezent.com
Founded	2017
Employees	1-10
Socials

FREZENT Biological Solutions Email Formats

FREZENT Biological Solutions uses 1 email format. The most common is {first initial} (e.g., j@frezent.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@frezent.com	100%

About FREZENT Biological Solutions

FREZENT is a preclinical-stage oncology therapeutics company based in New York. We are developing bispecific antibodies and antibody-drug conjugates aimed at targeting dormant cancer cells that may lead to cancer recurrence. Dormant cancer cells are small residual portions of a tumor that were not completely eliminated by treatment. These cells can remain undetectable in the body for a period of time, but eventually, they can transform back into fast-growing tumors. FREZENT is working on a novel cancer treatment to block the reactivation of dormant cancer cells. To achieve this, we are developing therapeutics that neutralize the metabolic factors supplied by the tumor microenvironment, which support dormant cancer cells. In their dormant state, cancer cells rely on these external supplies, and blocking them will effectively starve the cancer cells and induce cell death. Join us in our mission to ensure a future where long-lasting remission is a reality for all cancer patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Manager

Founder/Owner

Intern

Employees by Department

FREZENT Biological Solutions has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore FREZENT Biological Solutions's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-26	3	N/A
2024-12-01	3	N/A

Funding Insights

Number of funding rounds

FREZENT Biological Solutions Tech Stack

Discover the technologies and tools that power FREZENT Biological Solutions's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Emotion

Development

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

GoDaddy

Hosting

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

Frequently asked questions

FREZENT Biological Solutions is located in Manhattan, New York, US.

FREZENT Biological Solutions generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

FREZENT Biological Solutions has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

FREZENT Biological Solutions was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

FREZENT Biological Solutions has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at FREZENT Biological Solutions

Natasha Shtraizent

Founder, Chief Executive Officer

4.8

40,000 users